Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants (Q35056256)

6 August 2017

title

Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants (English)

1 reference

6 August 2017

0 references

Diana Di Gioia

1

1 reference

6 August 2017

Irene Aloisio

series ordinal

2

1 reference

6 August 2017

Giuseppe Mazzola

series ordinal

3

1 reference

6 August 2017

Bruno Biavati

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

28 November 2013

1 reference

Applied Microbiology and Biotechnology

6 August 2017

published in

1 reference

6 August 2017

volume

98

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

563-577

1 reference

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics for necrotizing enterocolitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Mode of delivery affects the bacterial community in the newborn gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Undiagnosed coeliac disease at age seven: population based prospective birth cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The role of probiotics in the management of allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Examining the hygiene hypothesis: the Trial of Infant Probiotic Supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The microbiome-gut-brain axis: from bowel to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Intestinal microbiota of infants with colic: development and specific signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Evidence-based guidelines for use of probiotics in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Coeliac disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Molecular monitoring of succession of bacterial communities in human neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

21 January 2018

Mood and gut feelings

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Safety of probiotics: comparison of two popular strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Patterns of early gut colonization shape future immune responses of the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

The intestinal microbiome of infants and the use of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics: potential pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Epidemiologic Evidence for the Fetal Overnutrition Hypothesis: Findings from the Mater-University Study of Pregnancy and Its Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Gliadin as a stimulator of innate responses in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

A longitudinal study of infant faecal microbiota during weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Fecal microbiota in premature infants prior to necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

RETRACTED ARTICLE: Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Case-finding in coeliac disease should be intensified

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Effect of infant feeding on the risk of obesity across the life course: a quantitative review of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Early-onset group B streptococcal disease in the era of maternal screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Principles and clinical implications of the brain-gut-enteric microbiota axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Tryptophan metabolism in the central nervous system: medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Safety assessment of probiotics for human use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Molecular identification of coliform bacteria from colicky breastfed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Microbiota and SCFA in lean and overweight healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Bifidobacterium infantis 35624 protects against salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Microecology, obesity, and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Diversity of bifidobacteria within the infant gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Recent advances in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Effects of four Bifidobacteria on obesity in high-fat diet induced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00253-013-5405-9

10.1007/S00253-013-5405-9

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference